Skip to main content
Quest Diagnostics

Early Identification of Circulating Neuroendocrine Tumour Cells by Flow Cytometry Prior to Surgical Diagnosis

Early Identification of Circulating Neuroendocrine Tumour Cells by Flow Cytometry Prior to Surgical Diagnosis

Authors: Love JE, Ratliff VR, Kussick SJ, Shameli A

Citation: Br J Haematol. 2025 Sep 8. doi: 10.1111/bjh.70141. Online ahead of print.

Specialties: Oncology, Hematology, Coagulation

Disclaimer: One or more of the authors of this publication were employed at the time by PhenoPath Diagnostics, a subsidiary of Quest Diagnostics.

Related content

Conventional Cytogenetic Analysis of Constitutional Abnormalities: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee
Publication
Conventional Cytogenetic Analysis of Solid Tumor Abnormalities: A 25-Year Review of Proficiency Test Results from the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee
Publication
Prognostic Implications of the Immune Tumor Microenvironment in Patients With Pancreatic and Gastrointestinal Neuroendocrine Tumors
Publication
Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans
Audio Podcast
Enhancing Cancer Treatment Decisions With Ultrasensitive MRD Testing
Publication
Pseudoendocrine Sarcoma: Clinicopathologic, Molecular, and Epigenetic Features of One Case

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.